DEXCOM INC
For the period ended Oct 29, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 29, 2026 · Filed Oct 29, 2026
Use the contents to explore the available documents and sections.
DXCM$79.41-6.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (In millions, except par value data)
(In millions, except par value data)
| September 30, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $961.4 | $917.7 |
| Short-term marketable securities | 856.5 | 1,081.0 |
| Accounts receivable, net | 1,186.2 | 1,216.1 |
| Inventory | 770.7 | 629.1 |
| Prepaid and other current assets | 141.2 | 189.4 |
| Total current assets | 3,916.0 | 4,033.3 |
| Property and equipment, net | 1,543.1 | 1,559.9 |
| Operating lease right-of-use assets | 83.7 | 77.4 |
| Goodwill | 24.0 | 24.2 |
| Intangibles, net | 89.4 | 70.8 |
| Deferred tax assets | 305.4 | 295.6 |
| Other assets | 277.2 | 278.7 |
| Total assets | $6,238.8 | $6,339.9 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities | $2,065.6 | $1,944.0 |
| Accrued payroll and related expenses | 159.7 | 169.2 |
| Short-term operating lease liabilities | 20.7 | 21.6 |
| Other current liabilities | 6.6 | 7.7 |
| Total current liabilities | 2,252.6 | 2,142.5 |
| Long-term senior convertible notes | 1,243.7 | 1,240.9 |
| Long-term operating lease liabilities | 77.5 | 73.4 |
| Other long-term liabilities | 129.6 | 137.1 |
| Total liabilities | 3,703.4 | 3,593.9 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at September 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value, 800.0 million shares authorized; 412.7 million and 373.0 million shares issued and outstanding, respectively, at September 30, 2026; and 410.7 million and 384.8 million shares issued and outstanding, respectively, at December 31, 2025 | 0.4 | 0.4 |
| Additional paid-in capital | 2,425.3 | 2,281.5 |
| Accumulated other comprehensive income | 85.5 | 115.0 |
| Retained earnings | 3,157.6 | 2,433.9 |
| Treasury stock, at cost; 39.7 million shares at September 30, 2026 and 25.9 million shares at December 31, 2025 | (3,133.4) | (2,084.8) |
| Total stockholders’ equity | 2,535.4 | 2,746.0 |
| Total liabilities and stockholders’ equity | $6,238.8 | $6,339.9 |
Table B
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.